- Home
- VMAR vs XBIO Comparison
VMAR vs XBIO Comparison
Compare VMAR & XBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VMAR
- XBIO
- Stock Information
- Founded
- VMAR 1995
- XBIO N/A
- Country
- VMAR Canada
- XBIO United States
- Employees
- VMAR N/A
- XBIO N/A
- Industry
- VMAR Marine Transportation
- XBIO Biotechnology: Pharmaceutical Preparations
- Sector
- VMAR Industrials
- XBIO Health Care
- Exchange
- VMAR Nasdaq
- XBIO Nasdaq
- Market Cap
- VMAR 5.9M
- XBIO 4.9M
- IPO Year
- VMAR 2020
- XBIO N/A
- Fundamental
- Price
- VMAR $1.94
- XBIO $2.86
- Analyst Decision
- VMAR
- XBIO Hold
- Analyst Count
- VMAR 0
- XBIO 1
- Target Price
- VMAR N/A
- XBIO N/A
- AVG Volume (30 Days)
- VMAR 1.3M
- XBIO 44.3K
- Earning Date
- VMAR 07-11-2025
- XBIO 08-13-2025
- Dividend Yield
- VMAR N/A
- XBIO N/A
- EPS Growth
- VMAR N/A
- XBIO N/A
- EPS
- VMAR N/A
- XBIO N/A
- Revenue
- VMAR $1,128,568.00
- XBIO $2,446,221.00
- Revenue This Year
- VMAR N/A
- XBIO $10.15
- Revenue Next Year
- VMAR $264.29
- XBIO $11.11
- P/E Ratio
- VMAR N/A
- XBIO N/A
- Revenue Growth
- VMAR N/A
- XBIO N/A
- 52 Week Low
- VMAR $1.86
- XBIO $2.20
- 52 Week High
- VMAR $658.67
- XBIO $5.27
- Technical
- Relative Strength Index (RSI)
- VMAR 14.50
- XBIO 37.55
- Support Level
- VMAR $4.87
- XBIO $2.63
- Resistance Level
- VMAR $5.17
- XBIO $3.00
- Average True Range (ATR)
- VMAR 0.40
- XBIO 0.22
- MACD
- VMAR -0.31
- XBIO -0.04
- Stochastic Oscillator
- VMAR 1.85
- XBIO 22.49
About VMAR Vision Marine Technologies Inc.
Vision Marine Technologies Inc is in the business of designing and manufacturing electric outboard powertrain systems, power boats, and related technology and the renting of electric boats. The different models of the powerboats and electric boats manufactured by the company include Bruce 22, Fantail 217, Volt 180, and others. The company operates in two reportable business segments; Sale of electric boats and Rental of electric boats. The majority of the revenue for the company is generated from the Sale of electric boats segment. Geographically, the company generates revenue from its business in Canada, USA and other countries. A substantial portion of the overall revenue is generated from its business in USA.
About XBIO Xenetic Biosciences Inc.
Xenetic Biosciences Inc is a biopharmaceutical company focused on advancing innovative immuno-oncology technologies addressing difficult to treat cancers. The company's DNase technology is designed to improve outcomes of existing treatments, including immunotherapies, by targeting neutrophil extracellular traps (NETs), which are involved in the progression of many human cancers. Xenetic is also focused on advancing its systemic DNase program into the clinic as an adjunctive therapy for pancreatic carcinoma and other locally metastatic solid tumors.